OBJECTIVE
To compare the retention and disease activity trajectories of subsequent biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) after Janus kinase inhibitor (JAKi) discontinuation in patients with rheumatoid arthritis (RA).
METHODS
We analysed 500 treatment courses (TCs) from the...
Yuhei Fujisawa, R. Watanabe, Yuya Yano et al.· Rheumatology· 0 citations
Systemic autoimmune diseases arise from a heterogeneous interplay of genetic, epigenetic, and environmental factors that culminates in loss of tolerance, chronic inflammation, and tissue injury. Among the pathways linking susceptibility to effector disease, CD40-CD40L is a central regulator of antigen presentation, T-B...
M. Hashimoto, M. Katsushima, F. Mackay et al.· Rheumatology· 0 citations
ObjectiveTo characterize the burden of herpes zoster (HZ) in systemic lupus erythematosus (SLE) and to examine clinical correlates of HZ and patients' attitudes toward the recombinant zoster vaccine (RZV).MethodsWe conducted a single-center retrospective cohort study combined with a cross-sectional survey among consecu...
Yuhei Fujisawa, R. Watanabe, Ryuhei Ishihara et al.· Lupus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.